Recent clinical trials of iodixanol

Reviews in Cardiovascular Medicine

Volumn 4, Issue SUPPL. 5, 2003, Pages

  Erdogan, Ata ^a   Davidson, Charles J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cardiac catheterization; Contrast media; Nephropathy

Indexed keywords

ACETYLCYSTEINE; CONTRAST MEDIUM; CREATININE; IODIXANOL; IOHEXOL; IOXAGLIC ACID; METFORMIN; NONIONIC CONTRAST MEDIUM; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG INDUCED DISEASE; DRUG USE; HEALTH CARE COST; HUMAN; HYDRATION; INCIDENCE; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; MORBIDITY; MORTALITY; MULTICENTER STUDY; NEPHROTOXICITY; OSMOLARITY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS;

CLINICAL TRIALS; CONFIDENCE INTERVALS; CONTRAST MEDIA; DIABETES COMPLICATIONS; HUMANS; KIDNEY DISEASES; OSMOLAR CONCENTRATION; TRIIODOBENZOIC ACIDS;

EID: 0346271509     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology. 1993;188:171-178.
2. Davidson CJ, Hlatky M, Morris KG, et al. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial. Ann Intern Med. 1989;110:119-124.
3. Schwab SJ, Hlatky M, Pieper KS, et al. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med. 1989;320:149-153.
4. Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int. 1995;47:254-261.
5. Deray G, Bagnis C, Jacquiaud C, et al. Renal effects of low and iso-osmolar contrast media on renal hemodynamics in a normal and ischemic dog kidney. Invest Radiol. 1999;34:1-4.
6. Chalmers N, Jackson RW. Comparison of iodixanol and iohexol in renal impairment. Br J Radiol. 1999;72:701-703.
7. Aspelin P, Aubry P, Fransson S, et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003;348:491-499.
8. Baker CS, Wragg A, Kumar S, et al. A rapid protocol for the prevention of contrast induced renal dysfunction: the RAPPID study. J Am Coll Cardiol. 2003;41:2114-2118.
9. Aspelin P, Berg KJ. Nephropathy induced by contrast medium [Letter to the Editor]. N Engl J Med. 2003;348:2257-2259.
10. Tepel M, van der Giet M, Schwarzfeld C, et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000; 343:180-184.
11. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259-2264.
12. Levy EM, Viscoli CM, Horwitz RJ. The effect of acute renal failure on mortality: a cohort analysis. JAMA. 1996;275:1489-1494.
13. Davidson CJ, Laskey WK, Hermiller JB, et al. Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial. Circulation. 2000;101:2172-2177.
14. Solomon R, Werner C, Mann D, et al. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med. 1994;331:1416-1420.
15. Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy. Arch Intern Med. 2002; 162:329-336.
16. Weisberg LS, Kurnik PB, Kurnik BRC. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int. 1994;45:259-265.
17. Stone GW, McCullough P, Tumlin J, et al. A prospective randomized placebo controlled multicenter trial evaluation fenoldopam mesylate for the prevention of contrast induced nephropathy: the CONTRAST. Trial [abstract]. J Am Coll Cardiol. 2003;41:83A.
18. Wang A, Holcslaw T, Bashore T, et al. Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int. 2000;57:1675-1680
19. Cacoub P, Deray G, Baumelou A, Jacobs C. No evidence for protective effects of nifedipine against radiocontrast-induced acute renal failure [letter]. Clin Nephrol. 1988;29:215-216.
20. Powe NR, Davidoff AJ, Moore RD, et al. Net costs from three perspectives of using low versus high osmolality contrast medium in diagnostic angiocardiography. J Am Coll Cardiol. 1993;21:1701-1709.